Hawaii 2024 Regular Session

Hawaii Senate Bill SB279 Compare Versions

OldNewDifferences
1-THE SENATE S.B. NO. 279 THIRTY-SECOND LEGISLATURE, 2023 S.D. 1 STATE OF HAWAII H.D. 1 A BILL FOR AN ACT RELATING TO HEALTH. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
1+THE SENATE S.B. NO. 279 THIRTY-SECOND LEGISLATURE, 2023 S.D. 1 STATE OF HAWAII A BILL FOR AN ACT RELATING TO HEALTH. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
22
33 THE SENATE S.B. NO. 279
44 THIRTY-SECOND LEGISLATURE, 2023 S.D. 1
5-STATE OF HAWAII H.D. 1
5+STATE OF HAWAII
66
77 THE SENATE
88
99 S.B. NO.
1010
1111 279
1212
1313 THIRTY-SECOND LEGISLATURE, 2023
1414
1515 S.D. 1
1616
1717 STATE OF HAWAII
1818
19-H.D. 1
19+
2020
2121
2222
2323
2424
2525
2626
2727
2828
2929
3030
3131 A BILL FOR AN ACT
3232
3333
3434
3535
3636
3737 RELATING TO HEALTH.
3838
3939
4040
4141
4242
4343 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
4444
4545
4646
47- SECTION 1. The legislature recognizes that the State has a duty to protect and improve the health and environment of the people. The legislature finds that a number of state residents suffer from depression. The legislature also finds that according to an article published in Current Neuropharmacology, the use of ketamine is a valid antidepressant option for the treatment of treatment-resistant depression and has rapid antidepressant effects. The purpose of this Act is to require medicaid and private insurance to cover ketamine therapy to treat depression. SECTION 2. Chapter 346, Hawaii Revised Statutes, is amended by adding a new section to part I to be appropriately designated and to read as follows: "§346- Coverage for ketamine therapy. Beginning on January 1, 2025, the State's medicaid programs shall provide coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by licensed psychiatrists, medical doctors, or other medical professionals authorized to prescribe ketamine." SECTION 3. Chapter 431, Hawaii Revised Statutes, is amended by adding a new section to part I of article 10A to be appropriately designated and to read as follows: "§431:10A- Coverage for ketamine therapy. Each individual or group policy of accident and health or sickness insurance policy issued or renewed in this State on or after January 1, 2025, shall provide to the policyholder and individuals covered under the policy coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by licensed psychiatrists, medical doctors, or other medical professionals authorized to prescribe ketamine." SECTION 4. Chapter 432, Hawaii Revised Statutes, is amended by adding a new section to part VI of article I to be appropriately designated and to read as follows: "§432:1- Coverage for ketamine therapy. Each individual or group hospital or medical service plan contract issued or renewed in this State on or after January 1, 2025, shall provide to the member and individuals covered under the plan contract coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by licensed psychiatrists, medical doctors, or other medical professionals authorized to prescribe ketamine." SECTION 5. Section 432D-23, Hawaii Revised Statutes, is amended to read as follows: "§432D-23 Required provisions and benefits. Notwithstanding any provision of law to the contrary, each policy, contract, plan, or agreement issued in the State after January 1, 1995, by health maintenance organizations pursuant to this chapter, shall include benefits provided in sections 431:10-212, 431:10A-115, 431:10A-115.5, 431:10A-116, 431:10A‑116.2, 431:10A-116.5, 431:10A-116.6, 431:10A-119, 431:10A-120, 431:10A-121, 431:10A-122, 431:10A-125, 431:10A-126, 431:10A-132, 431:10A-133, 431:10A-134, 431:10A-140, and [431:10A-134,] 431:10A- , and chapter 431M." SECTION 6. In accordance with section 9 of article VII of the Hawaii State Constitution and sections 3791 and 3793, Hawaii Revised Statutes, the legislature has determined that the appropriations contained in H.B. No. , will cause the state general fund expenditure ceiling for fiscal year 20242025 to be exceeded by $ or per cent. In addition, the appropriation contained in this Act will cause the general fund expenditure ceiling for fiscal year 20242025 to be further exceeded by $ or per cent. The combined total amount of general fund appropriations contained in only these two Acts will cause the state general fund expenditure ceiling for fiscal year 2024‑2025 to be exceeded by $ or per cent. The reasons for exceeding the general fund expenditure ceiling are that: (1) The appropriation made in this Act is necessary to serve the public interest; and (2) The appropriation made in this Act meets the needs addressed by this Act. SECTION 7. There is appropriated out of the general revenues of the State of Hawaii the sum of $ or so much thereof as may be necessary for fiscal year 2024-2025 for costs arising from the coverage of ketamine therapy required or authorized under section 2 of this Act. The sum appropriated shall be expended by the department of human services for the purposes of this Act. SECTION 8. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored. SECTION 9. This Act shall take effect on July 1, 2040; provided that section 2 of this Act shall take effect upon approval of the Hawaii medicaid state plan by the Centers for Medicare and Medicaid Services.
47+ SECTION 1. The legislature recognizes that the State has a duty to protect and improve the health and environment of the people. The legislature finds that a number of state residents suffer from depression. The legislature also finds that according to an article published in Current Neuropharmacology, the use of ketamine is a valid antidepressant option for the treatment of treatment-resistant depression and has rapid antidepressant effects. The purpose of this Act is to require medicaid and insurance coverage of ketamine therapy. SECTION 2. Chapter 346, Hawaii Revised Statutes, is amended by adding a new section to part I to be appropriately designated and to read as follows: "§346- Coverage for ketamine therapy. Beginning on January 1, 2024, the State's medicaid programs shall provide coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals." SECTION 3. Chapter 431, Hawaii Revised Statutes, is amended by adding a new section to part I of article 10A to be appropriately designated and to read as follows: "§431:10A- Coverage for ketamine therapy. Each individual or group accident and health or sickness insurance policy issued or renewed in this State on or after January 1, 2024, shall provide to the policyholder and individuals covered under the policy coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals." SECTION 4. Chapter 432, Hawaii Revised Statutes, is amended by adding a new section to part VI of article I to be appropriately designated and to read as follows: "§432:1- Coverage for ketamine therapy. Each hospital or medical service plan contract issued or renewed in this State on or after January 1, 2024, shall provide to the member and individuals covered under the plan contract coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals." SECTION 5. Section 432D-23, Hawaii Revised Statutes, is amended to read as follows: "§432D-23 Required provisions and benefits. Notwithstanding any provision of law to the contrary, each policy, contract, plan, or agreement issued in the State after January 1, 1995, by health maintenance organizations pursuant to this chapter, shall include benefits provided in sections 431:10-212, 431:10A-115, 431:10A-115.5, 431:10A-116, 431:10A‑116.2, 431:10A-116.5, 431:10A-116.6, 431:10A-119, 431:10A-120, 431:10A-121, 431:10A-122, 431:10A-125, 431:10A-126, 431:10A-132, 431:10A-133, 431:10A-134, 431:10A-140, and [431:10A-134,] 431:10A- , and chapter 431M." SECTION 6. In accordance with section 9 of article VII of the Hawaii State Constitution and sections 37-91 and 37-93, Hawaii Revised Statutes, the legislature has determined that the appropriations contained in Act 164, Regular Session of 2023, and this Act will cause the state general fund expenditure ceiling for fiscal year 2024-2025 to be exceeded by $ or per cent. This current declaration takes into account general fund appropriations authorized for fiscal year 2024-2025 in Act 164, Regular Session of 2023, and this Act only. The reasons for exceeding the general fund expenditure ceiling are that: (1) The appropriation made in this Act is necessary to serve the public interest; and (2) The appropriation made in this Act meets the needs addressed by this Act. SECTION 7. There is appropriated out of the general revenues of the State of Hawaii the sum of $ or so much thereof as may be necessary for fiscal year 2024-2025 for costs arising from the coverage of ketamine therapy required or authorized under section 2 of this Act. The sum appropriated shall be expended by the department of human services for the purposes of this Act. SECTION 8. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored. SECTION 9. This Act shall take effect on July 1, 2040; provided that section 2 of this Act shall take effect upon approval of the Hawaii medicaid state plan by the Centers for Medicare and Medicaid Services.
4848
4949 SECTION 1. The legislature recognizes that the State has a duty to protect and improve the health and environment of the people. The legislature finds that a number of state residents suffer from depression. The legislature also finds that according to an article published in Current Neuropharmacology, the use of ketamine is a valid antidepressant option for the treatment of treatment-resistant depression and has rapid antidepressant effects.
5050
51- The purpose of this Act is to require medicaid and private insurance to cover ketamine therapy to treat depression.
51+ The purpose of this Act is to require medicaid and insurance coverage of ketamine therapy.
5252
5353 SECTION 2. Chapter 346, Hawaii Revised Statutes, is amended by adding a new section to part I to be appropriately designated and to read as follows:
5454
55- "§346- Coverage for ketamine therapy. Beginning on January 1, 2025, the State's medicaid programs shall provide coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by licensed psychiatrists, medical doctors, or other medical professionals authorized to prescribe ketamine."
55+ "§346- Coverage for ketamine therapy. Beginning on January 1, 2024, the State's medicaid programs shall provide coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals."
5656
5757 SECTION 3. Chapter 431, Hawaii Revised Statutes, is amended by adding a new section to part I of article 10A to be appropriately designated and to read as follows:
5858
59- "§431:10A- Coverage for ketamine therapy. Each individual or group policy of accident and health or sickness insurance policy issued or renewed in this State on or after January 1, 2025, shall provide to the policyholder and individuals covered under the policy coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by licensed psychiatrists, medical doctors, or other medical professionals authorized to prescribe ketamine."
59+ "§431:10A- Coverage for ketamine therapy. Each individual or group accident and health or sickness insurance policy issued or renewed in this State on or after January 1, 2024, shall provide to the policyholder and individuals covered under the policy coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals."
6060
6161 SECTION 4. Chapter 432, Hawaii Revised Statutes, is amended by adding a new section to part VI of article I to be appropriately designated and to read as follows:
6262
63- "§432:1- Coverage for ketamine therapy. Each individual or group hospital or medical service plan contract issued or renewed in this State on or after January 1, 2025, shall provide to the member and individuals covered under the plan contract coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by licensed psychiatrists, medical doctors, or other medical professionals authorized to prescribe ketamine."
63+ "§432:1- Coverage for ketamine therapy. Each hospital or medical service plan contract issued or renewed in this State on or after January 1, 2024, shall provide to the member and individuals covered under the plan contract coverage for per cent of the costs of ketamine therapy to treat depression in qualifying patients, as determined by qualified psychiatrists or other mental health professionals."
6464
6565 SECTION 5. Section 432D-23, Hawaii Revised Statutes, is amended to read as follows:
6666
6767 "§432D-23 Required provisions and benefits. Notwithstanding any provision of law to the contrary, each policy, contract, plan, or agreement issued in the State after January 1, 1995, by health maintenance organizations pursuant to this chapter, shall include benefits provided in sections 431:10-212, 431:10A-115, 431:10A-115.5, 431:10A-116, 431:10A‑116.2, 431:10A-116.5, 431:10A-116.6, 431:10A-119, 431:10A-120, 431:10A-121, 431:10A-122, 431:10A-125, 431:10A-126, 431:10A-132, 431:10A-133, 431:10A-134, 431:10A-140, and [431:10A-134,] 431:10A- , and chapter 431M."
6868
69- SECTION 6. In accordance with section 9 of article VII of the Hawaii State Constitution and sections 3791 and 3793, Hawaii Revised Statutes, the legislature has determined that the appropriations contained in H.B. No. , will cause the state general fund expenditure ceiling for fiscal year 20242025 to be exceeded by $ or per cent. In addition, the appropriation contained in this Act will cause the general fund expenditure ceiling for fiscal year 20242025 to be further exceeded by $ or per cent. The combined total amount of general fund appropriations contained in only these two Acts will cause the state general fund expenditure ceiling for fiscal year 2024‑2025 to be exceeded by $ or per cent. The reasons for exceeding the general fund expenditure ceiling are that:
69+ SECTION 6. In accordance with section 9 of article VII of the Hawaii State Constitution and sections 37-91 and 37-93, Hawaii Revised Statutes, the legislature has determined that the appropriations contained in Act 164, Regular Session of 2023, and this Act will cause the state general fund expenditure ceiling for fiscal year 2024-2025 to be exceeded by $ or per cent. This current declaration takes into account general fund appropriations authorized for fiscal year 2024-2025 in Act 164, Regular Session of 2023, and this Act only. The reasons for exceeding the general fund expenditure ceiling are that:
7070
7171 (1) The appropriation made in this Act is necessary to serve the public interest; and
7272
7373 (2) The appropriation made in this Act meets the needs addressed by this Act.
7474
7575 SECTION 7. There is appropriated out of the general revenues of the State of Hawaii the sum of $ or so much thereof as may be necessary for fiscal year 2024-2025 for costs arising from the coverage of ketamine therapy required or authorized under section 2 of this Act.
7676
7777 The sum appropriated shall be expended by the department of human services for the purposes of this Act.
7878
7979 SECTION 8. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
8080
8181 SECTION 9. This Act shall take effect on July 1, 2040; provided that section 2 of this Act shall take effect upon approval of the Hawaii medicaid state plan by the Centers for Medicare and Medicaid Services.
8282
83- Report Title: Health Insurance; Medicaid; Mandated Coverage; Ketamine Therapy; Appropriation; Expenditure Ceiling Description: Requires Medicaid and private insurance coverage for ketamine therapy to treat depression. Appropriates funds. Effective 7/1/2040. (HD1) The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
84-
85-
83+ Report Title: Health; Health Insurance; Medicaid; Mandated Coverage; Ketamine Therapy; Expenditure Ceiling; Appropriation Description: Requires Medicaid and insurance coverage for ketamine therapy to treat depression. Makes an appropriation for costs resulting from Medicaid coverage for ketamine therapy. Declares that the general fund expenditure ceiling is exceeded. Takes effect 7/1/2040. (SD1) The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
8684
8785
8886
8987 Report Title:
9088
91-Health Insurance; Medicaid; Mandated Coverage; Ketamine Therapy; Appropriation; Expenditure Ceiling
89+Health; Health Insurance; Medicaid; Mandated Coverage; Ketamine Therapy; Expenditure Ceiling; Appropriation
9290
9391
9492
9593 Description:
9694
97-Requires Medicaid and private insurance coverage for ketamine therapy to treat depression. Appropriates funds. Effective 7/1/2040. (HD1)
95+Requires Medicaid and insurance coverage for ketamine therapy to treat depression. Makes an appropriation for costs resulting from Medicaid coverage for ketamine therapy. Declares that the general fund expenditure ceiling is exceeded. Takes effect 7/1/2040. (SD1)
9896
9997
10098
10199
102100
103101
104102
105103 The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.